Cocrystal Pharma (COCP) Debt Ratio (2010 - 2013)

Cocrystal Pharma (COCP) posted Debt Ratio of 0.39 for Q2 2013, down 18.36% sequentially from 0.47 in Q1 2013, and up 3.48% YoY from 0.37 in Q2 2012.

Cocrystal Pharma (COCP) Debt Ratio (2010 - 2013) Analysis & Trends

Cocrystal Pharma has reported Debt Ratio for 4 years, with the latest figure at 0.39 in Q2 2013.

Quarterly Debt Ratio rose 3.48% year-over-year to 0.39 in Q2 2013, while the trailing twelve-month figure through Jun 2013 was 0.39 (up 3.48% YoY) and the FY2012 annual result came in at 0.45, down 4.58% from the prior year.
Debt Ratio eased to 0.39 in Q2 2013 per COCP's latest filing, from 0.47 in the prior quarter.
Over five years, Debt Ratio peaked at 0.47 in Q1 2013 and troughed at 0.31 in Q2 2011.
A 4-year average of 0.4 and a median of 0.4 in 2012 frame the typical range for Debt Ratio.
The widest YoY moves for Debt Ratio: up 20.5% in 2012, down 4.58% in 2012.
Over 4 years, Debt Ratio stood at 0.44 in 2010, then grew by 6.97% to 0.47 in 2011, then dropped by 4.58% to 0.45 in 2012, then declined by 14.09% to 0.39 in 2013.
According to Business Quant data, Debt Ratio over the past three periods registered 0.39, 0.47, and 0.45 for Q2 2013, Q1 2013, and Q4 2012 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	0.05
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	-
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	0.05
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	0.12
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	0.26
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	0.47
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	0.03
10	Cocrystal Pharma	15.86 Mn	13.54 Mn	-	-

Download Data